Correlation Between Rossari Biotech and AXISCADES Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Rossari Biotech and AXISCADES Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rossari Biotech and AXISCADES Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rossari Biotech Limited and AXISCADES Technologies Limited, you can compare the effects of market volatilities on Rossari Biotech and AXISCADES Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rossari Biotech with a short position of AXISCADES Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rossari Biotech and AXISCADES Technologies.

Diversification Opportunities for Rossari Biotech and AXISCADES Technologies

0.65
  Correlation Coefficient

Poor diversification

The 3 months correlation between Rossari and AXISCADES is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Rossari Biotech Limited and AXISCADES Technologies Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AXISCADES Technologies and Rossari Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rossari Biotech Limited are associated (or correlated) with AXISCADES Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AXISCADES Technologies has no effect on the direction of Rossari Biotech i.e., Rossari Biotech and AXISCADES Technologies go up and down completely randomly.

Pair Corralation between Rossari Biotech and AXISCADES Technologies

Assuming the 90 days trading horizon Rossari Biotech is expected to generate 4.92 times less return on investment than AXISCADES Technologies. But when comparing it to its historical volatility, Rossari Biotech Limited is 1.62 times less risky than AXISCADES Technologies. It trades about 0.08 of its potential returns per unit of risk. AXISCADES Technologies Limited is currently generating about 0.24 of returns per unit of risk over similar time horizon. If you would invest  85,470  in AXISCADES Technologies Limited on April 22, 2025 and sell it today you would earn a total of  50,830  from holding AXISCADES Technologies Limited or generate 59.47% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Rossari Biotech Limited  vs.  AXISCADES Technologies Limited

 Performance 
       Timeline  
Rossari Biotech 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Rossari Biotech Limited are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Rossari Biotech may actually be approaching a critical reversion point that can send shares even higher in August 2025.
AXISCADES Technologies 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in AXISCADES Technologies Limited are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, AXISCADES Technologies exhibited solid returns over the last few months and may actually be approaching a breakup point.

Rossari Biotech and AXISCADES Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Rossari Biotech and AXISCADES Technologies

The main advantage of trading using opposite Rossari Biotech and AXISCADES Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rossari Biotech position performs unexpectedly, AXISCADES Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AXISCADES Technologies will offset losses from the drop in AXISCADES Technologies' long position.
The idea behind Rossari Biotech Limited and AXISCADES Technologies Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm